2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
暂无分享,去创建一个
M. Link | D. DeMets | Jeffrey L. Anderson | W. Stevenson | C. Tracy | C. Yancy | L. Newby | E. Ohman | J. Halperin | A. Jacobs | G. Gregoratos | K. Ellenbogen | R. Page | T. Ferguson | M. Hlatky | A. Gillinov | J. Dimarco | N. Albert | J. Hochman | L. Stevenson | M. Sweeney | D. Hayes | L. Gettes | R. Guyton | M. Creager | M. Silka | W. Stevenson | P. Varosy | D. Darbar | S. Hammill | J. Marine | M. Schoenfeld | R. Freedman | F. Kushner | S. Ettinger | S. Dunbar | A. Epstein | N. Estes | P. Karasik | Amit J. Shanker | N. Mark Estes | L. Kristin Newby | Jeffrey L. Anderson | A. Marc Gillinov | Andrew E Epstein | Lynne Warner Stevenson | A. Jacobs
[1] R. Lazzara,et al. The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta‐Analysis , 2012, Journal of cardiovascular electrophysiology.
[2] Nancy M Albert,et al. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. , 2012, Journal of cardiac failure.
[3] Jagmeet P. Singh,et al. Biventricular pacing: current trends and future strategies. , 2012, European heart journal.
[4] Wojciech Zareba,et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[5] Philippe Mabo,et al. A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial) , 2011, European heart journal.
[6] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[7] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.
[8] David O. Martin,et al. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology. , 2011, The American journal of cardiology.
[9] M. Brignole,et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. , 2011, European heart journal.
[10] D. Rowland,et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2011, Archives of internal medicine.
[11] Jeroen J. Bax,et al. Cardiac resynchronization therapy in paediatric and congenital heart disease patients. , 2011, European heart journal.
[12] Michael J Ackerman,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] S. Saba,et al. Predicting Hyperresponse Among Pacemaker‐Dependent Nonischemic Cardiomyopathy Patients Upgraded to Cardiac Resynchronization , 2011, Journal of cardiovascular electrophysiology.
[14] H. Calkins,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.
[15] W. Ghali,et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. , 2011, Heart rhythm.
[16] Paul J. Wang,et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.
[17] Wojciech Zareba,et al. Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.
[18] A. Boyle,et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.
[19] Finn Gustafsson,et al. 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .
[20] S. Greenfield,et al. Clinical practice guidelines we can trust , 2011 .
[21] Laura A. Levit,et al. Finding what works in health care : standards for systematic reviews , 2011 .
[22] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[23] P. Heidenreich,et al. Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.
[24] R. Ariga,et al. Greater Three‐Dimensional Ventricular Lead Tip Separation is Associated with Improved Outcome after Cardiac Resynchronization Therapy , 2010, Pacing and clinical electrophysiology : PACE.
[25] Kevin Vernooy,et al. Mechano-energetics of the asynchronous and resynchronized heart , 2010, Heart Failure Reviews.
[26] Kenneth C Bilchick,et al. Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients , 2010, Circulation.
[27] M. Ackerman,et al. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. , 2010, Heart rhythm.
[28] J. Daubert,et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[29] L. Jordaens,et al. Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry , 2010, Circulation.
[30] R. Schweikert,et al. Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.
[31] Pier Giorgio Masci,et al. Myocardial Structural, Perfusion, and Metabolic Correlates of Left Bundle Branch Block Mechanical Derangement in Patients With Dilated Cardiomyopathy: A Tagged Cardiac Magnetic Resonance and Positron Emission Tomography Study , 2010, Circulation. Cardiovascular imaging.
[32] G. Annas,et al. Hrs Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (cieds) in Patients Nearing End of Life or Requesting Withdrawal of Therapy Introduction , 2022 .
[33] David O. Martin,et al. Cardiac Resynchronization Therapy in Non‐Left Bundle Branch Block Morphologies , 2009, Pacing and clinical electrophysiology : PACE.
[34] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[35] Hongyan Qiao,et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. , 2009, Journal of the American College of Cardiology.
[36] M. Gold,et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.
[37] R. Sutton,et al. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices. , 2009, The American journal of cardiology.
[38] S. Saba,et al. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. , 2009, The American journal of cardiology.
[39] Stefano Ghio,et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.
[40] K. Ellenbogen,et al. Benefit of Primary Prevention Implantable Cardioverter‐Defibrillators in the Setting of Chronic Kidney Disease: A Decision Model Analysis , 2008, Journal of cardiovascular electrophysiology.
[41] J. Knuuti,et al. Effects of CRT on myocardial innervation, perfusion and metabolism. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[42] Jagmeet P. Singh,et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.
[43] J. Triedman. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenit , 2008, Circulation. Arrhythmia and electrophysiology.
[44] S. Priori,et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. , 2008, Heart rhythm.
[45] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.
[46] J. Triedman,et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.
[47] L. Harris,et al. Implantable Cardioverter-Defibrillators in Tetralogy of Fallot , 2008, Circulation.
[48] P. Tchou,et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.
[49] M. Maleki,et al. Prevalence of Mechanical Dyssynchrony in Heart Failure Patients with Different QRS Durations , 2007, Pacing and clinical electrophysiology : PACE.
[50] Leslie Saxon,et al. Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure , 2006, Circulation.
[51] Catherine Klersy,et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.
[52] F. Prinzen,et al. A new paradigm for physiologic ventricular pacing. , 2006, Journal of the American College of Cardiology.
[53] S. Barold,et al. Significance of QRS complex duration in patients with heart failure. , 2005, Journal of the American College of Cardiology.
[54] E. Daoud,et al. Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.
[55] Arjun D. Sharma,et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.
[56] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[57] P. Vardas,et al. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation , 2005 .
[58] Paul J. Wang,et al. The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.
[59] J. Schroeder,et al. Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.
[60] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[61] Jeroen J. Bax,et al. Relationship Between QRS Duration and Left Ventricular Dyssynchrony in Patients with End‐Stage Heart Failure , 2004, Journal of cardiovascular electrophysiology.
[62] K. Ellenbogen,et al. Resynchronization Therapy for the Treatment of Heart Failure , 2003, Circulation.
[63] S. Goodman,et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.
[64] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.
[65] Thomas Lavergne,et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.
[66] D. Delurgio,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[67] J. Spinelli,et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. , 2001, Journal of the American College of Cardiology.
[68] J. Daubert,et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.
[69] J. Blanc,et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.
[70] H. Doval,et al. Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.